INCOG BioPharma Services has purchased property on the north side of Fishers and is expanding the size of its planned biopharmaceutical manufacturing facility.
In October, INCOG BioPharma co-founders Cory Lewis and Tedd Green announced plans to build a $60 million contract-manufacturing service in Fishers that would help biopharmaceutical companies bring early-phase injectable drugs through the development process and to commercial launch.
Lewis confirmed Thursday that INCOG acquired a 16-acre parcel of undeveloped land as the site for an 80,000-square-foot facility at the northwest corner of Exit 5 Parkway and Cumberland Road, just south of I-69. Lewis declined to say how much INCog paid for the property.
“This is a long-term play,” Lewis said.
The property at 12050 Exit Five Parkway had been owned by Florida-based Sunbeam Development Corp. and is adjacent to Roto-Rooter Plumbing & Water Cleanup.
INCOG’s first phase of construction will be on the east side of the site, facing a four-acre pond. From there, Lewis expects the company to see several more phases of construction building westward.
Already, the project’s first phase has been increased from an estimated 50, 000 to 60,000 square feet to a total of 80,000 square feet.
“We’ve made the footprint bigger to accommodate things differently,” Lewis said. “We’re hoping to be able to expand at a faster rate, with less constraint.”
INCOG has selected Indianapolis-based Shiel Sexton as its general contractor.
“We’ll start clearing trees and moving dirt in January,” Lewis said. “We’re looking forward to that partnership with them on the construction, design, build part of the equation.”
Lewis said his company chose the property for its proximity to the city’s downtown, the interstate, the airport, nearby hotels and other amenities.
INCOG is expected to create 150 jobs by 2024 with an average salary of $83,000. Lewis said he’s confident the company will be able to find the workers it needs in a 10-mile to 20-mile radius.
Lewis was vice president of business development and marketing for the former Bloomington-based Cook Pharmica from 2009 to 2017, and Green served as Cook Pharmica’s president from 2008 to 2017. Both men stayed with the company after New Jersey-based Catalent Pharma Solutions bought Pharmica for $950 million in 2017.